Literature DB >> 32319548

[Corrigendum] S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.

Shuguang Pan1, Ying Hu2, Mengjia Hu1, Yang Xu1, Mo Chen1, Changhong Du1, Jinchi Cui3, Ping Zheng3, Jiejuan Lai3, Yujun Zhang3, Jie Bai3, Peng Jiang3, Jin Zhu3, Yu He3, Junping Wang1.   

Abstract

A growing body of evidence indicates that S100 calcium‑binding protein A8 (S100A8) is frequently overexpressed in malignant tumor tissues and regulates tumor progression; however, the role of S100A8 in cholangiocarcinoma (CCA) remains unclear. The present study demonstrated that the protein expression of S100A8 was significantly higher in pathological tissues compared with adjacent normal tissues from patients with CCA. In addition, S100A8 expression was significantly associated with differentiation, lymph node metastasis and poor prognosis in patients following surgical resection of CCA. Furthermore, both in vitro and in vivo experiments revealed that overexpression of S100A8 promoted, while S100A8 knockdown attenuated, the migration and metastasis of CCA cells. Of note, the present results indicated that S100A8 promoted the CCA tumor cell‑induced migration of vascular endothelial cells. Finally, S100A8 was demonstrated to positively regulate the expression of vascular endothelial growth factor (VEGF) in CCA cells, which was mediated by activation of the Toll‑like receptor 4 (TLR4)/NF‑κB pathway. In conclusion, the present study demonstrated that S100A8 had an important role in facilitating CCA cell migration and metastasis via upregulation of VEGF expression by activating the TLR4/NF‑κB pathway. These findings may provide a novel target for CCA treatment.[the original article was published in International Journal of Oncology 56: 101‑112, 2020; DOI: 10.3892/ijo.2019.4907].

Entities:  

Year:  2020        PMID: 32319548      PMCID: PMC7050978          DOI: 10.3892/ijo.2020.4977

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


Int J Oncol 56: 101-112, 2020; DOI: 10.3892/ijo.2019.4907 Subsequently to the publication of the above article, the authors have realized that, in the Abstract on p. 101, line 12 and in the fourth sentence, "S100A8" was erroneously written as "S100A6". The sentence in question should have read as follows: "Furthermore, both in vitro and in vivo experiments revealed that overexpression of S100A8 promoted, while S100A8 knockdown attenuated, the migration and metastasis of CCA cells." The authors regret that this error was not corrected before the article went to print, and apologize for any inconvenience caused.
  2 in total

Review 1.  Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Authors:  Fang Bao; Jiayue Liu; Haiyang Chen; Lu Miao; Zhaochao Xu; Guixin Zhang
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

2.  Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.

Authors:  Xiaoling Gao; Wenhao Zhang; Yanjuan Jia; Hui Xu; Yuchen Zhu; Xiong Pei
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.